La Revue Pharma
La Revue Pharma is a privately held B2B professional publishing platform serving French community pharmacists, pharmacy students, and pharmacy cooperatives with subscription-based digital and print content, training modules, and video programming under Expressions Pharma.
- Company typePrivate
- Founded2008
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2B
- OfferingServices
What La Revue Pharma does
La Revue Pharma is a privately held B2B professional publishing platform serving French community pharmacists (officine), pharmacy students, and pharmacy cooperatives. Founded in 2008 and operated by the parent entity Expressions Pharma from Paris, the company delivers a subscription-based digital and print magazine covering therapeutic updates, regulatory changes, clinical case studies, and pharmacy business management. The core product is a WordPress-based web platform combined with a print magazine, supplemented by PharmaTV video content, training modules (cahiers de formation), prescription case analyses, and ancillary services including a job board (Jobs de Pharma) and pharmacy transaction classifieds (Transactions Pharma).
The business model combines recurring annual subscriptions (unlimited digital access, print issues, newsletters, archives) with one-time purchases of individual articles at €8-16 and single print issues at €15. A free registration tier with limited content access drives top-of-funnel acquisition. The publication is monetized through a sales-led GTM motion via the website, supported by organic social media (Twitter/X with 6,890 followers, Facebook, Instagram, YouTube) and a monthly email newsletter. Content is segmented across "Actualités" (news), "Socio-Pro" (business), and "Thérapeutique" (therapeutic) verticals, with 230+ archived issues dating back to at least October 2008.
The company operates with a lean team of 6 employees, generates undisclosed revenue, and is not backed by disclosed institutional investors or public funding. Recent strategic moves include obtaining Qualiopi certification (2025-2028) for training activities, partnering with IQVIA France for pharmaceutical market data content (September 2024), and operating adjacent service lines including Transactions Pharma classifieds and the Jobs de Pharma career platform. The technology stack is WordPress-based with no proprietary AI/ML capabilities or disclosed integrations.
La Revue Pharma firmographics
Firmographics- Name
- La Revue Pharma
- Legal name
- Expressions Pharma
- Website
- https://revuepharma.fr
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- La Revue Pharma is a privately held B2B professional publishing platform serving French community pharmacists, pharmacy students, and pharmacy cooperatives with subscription-based digital and print content, training modules, and video programming under Expressions Pharma.
- Ownership category
- akta.pro rank
La Revue Pharma industry classification
Industry- Product category
- Professional Publishing / Pharmaceutical Trade Media
- NAICS
- Periodical Publishers (513120), Periodical Publishers (51312)
- SIC
- Periodicals: Publishing Or Publishing & Printing (2721)
- akta.pro primary industry
- Health, Fitness & Wellness Magazines (MPAJAEAD)
Keywords
Where La Revue Pharma is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
La Revue Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Subscription Revenue: Annual subscriptions providing unlimited digital access to all site content, print magazine copies delivered throughout the year, monthly newsletters, and access to digital archives.
- Individual Article Sales: Single articles available for purchase at 8€ per article (e.g., training case studies, practical guides). Some articles priced at 16€ for comprehensive content.
- Single Issue Sales: Individual print magazine issues sold at 15€ per copy, accessible through online purchase with digital access upon checkout.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Individual article purchase |
| One time/ perpetual license | Pay-as-you-go | Single print issue |
| Subscription | Annual | Full annual subscription |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
La Revue Pharma product offering
Product offeringCore offering
La Revue Pharma is a professional B2B publication for French pharmacists that delivers subscription-based digital and print magazine content covering therapeutic updates, drug information, socio-professional news, financial management, and continuing education. It sells individual articles (8-16€), single issues (15€), and annual subscriptions providing unlimited digital access, print copies, monthly newsletters, and digital archives.
Product overview
La Revue Pharma is a professional B2B publication for French pharmacists offering a unified platform combining subscription-based digital and print content, video programming (PharmaTV), professional training modules, and industry-specific services. The core product is the digital magazine featuring therapeutic content, prescription analyses, and pharmaceutical news, supplemented by PharmaTV video content, training modules (cahiers de formation), and ancillary services including job listings (Jobs de Pharma) and pharmacy transaction listings (Transactions Pharma). Subscription tiers include unlimited digital access, annual print issues, monthly newsletters, and archived content.
Differentiator
Problem solved
Functional benefit
Products and services
- Revue Pharma Digital Magazine
- Revue Pharma Print Magazine
- PharmaTV
- Training Modules (Cahiers de formation)
- Newsletter Revue Pharma
- La Collection (Archives)
- Jobs de Pharma
- Transactions Pharma
Companies that use La Revue Pharma
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
La Revue Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
La Revue Pharma partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
La Revue Pharma competitors and assessment
Company assessmentRegional players
- Pharmacy Times: US-based pharmacy trade publication offering continuing education, clinical content, and industry news — same B2B trade-publication model and CE/training angle, but focused on the US pharmacy market rather than France.
- The Pharmaceutical Journal (RPS): Royal Pharmaceutical Society's professional journal covering clinical, policy, and practice content for UK pharmacists — comparable peer-to-peer pharmacy media brand, serving a different national market.
Broad incumbents
- APMnews (Agence de Presse Médicale): Broader French healthcare news agency covering medicine, hospitals, pharma industry, and pharmacy — overlaps with Revue Pharma's news coverage as part of a wider healthcare portfolio.
Direct peers
- Le Quotidien du Pharmacien: Daily French pharmacy news publication (Groupe APMnews) serving the same Officine audience with therapeutic updates, regulatory news, and practice management content — closest direct competitor by audience and content category.
- Le Moniteur des Pharmacies: Long-established French trade publication for community pharmacists covering therapeutics, business management, and industry news — directly comparable in audience, format, and editorial scope to La Revue Pharma.
- Pharmaceutiques Magazine: French magazine targeting the pharmaceutical industry and pharmacy professionals with strategy, regulatory, and product news — comparable B2B trade-publication model, though more industry-pharma than community-pharmacy skewed.
- Le Pharmacien de France: Official-leaning French pharmacy professional magazine, historically tied to the national pharmacists' union — competing for the same Officine readership with similar editorial verticals.
- Egora: French healthcare professional media brand covering pharmacy and medicine with news, training content, and video — overlaps directly with Revue Pharma's therapeutic and socio-professional coverage.
Others
- Vidal: French drug reference database used daily by community pharmacists for monographs, interactions, and dispensing support — adjacent ecosystem tool competing for pharmacist attention/economic share rather than operating a similar media business.
- IQVIA France: Existing content partner providing market intelligence cited in Revue Pharma articles; adjacent data/analytics provider with deep relationships to the same pharmacist and groupement audience.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
La Revue Pharma social profiles
Digital presenceLa Revue Pharma compliance and trust
Trust signalCompliance1 record
La Revue Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
La Revue Pharma leadership team
Management profileNumber of profiles
Profiles1 record
La Revue Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
La Revue Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about La Revue Pharma
What does La Revue Pharma do?
La Revue Pharma is a professional B2B publication for French pharmacists that delivers subscription-based digital and print magazine content covering therapeutic updates, drug information, socio-professional news, financial management, and continuing education. It sells individual articles (8-16€), single issues (15€), and annual subscriptions providing unlimited digital access, print copies, monthly newsletters, and digital archives.
Is La Revue Pharma a public or private company?
La Revue Pharma is a private company. It is classified as unknown and is currently operating.
When was La Revue Pharma founded?
La Revue Pharma was founded in 2008. It employs 1 to 10 people.
Where is La Revue Pharma based?
La Revue Pharma is headquartered in Paris, France, in the Europe region.
How does La Revue Pharma make money?
Three revenue lines are on record. Subscription Revenue is the primary driver. The others are individual Article Sales and single Issue Sales.
Who are La Revue Pharma's main competitors?
Regional players on record are Pharmacy Times and The Pharmaceutical Journal (RPS). APMnews (Agence de Presse Médicale) is listed as a broad incumbent. Direct peers are Le Quotidien du Pharmacien, Le Moniteur des Pharmacies, Pharmaceutiques Magazine, Le Pharmacien de France and Egora. Others are Vidal and IQVIA France.
Does La Revue Pharma have an API?
No public API is recorded for La Revue Pharma.
What industry is La Revue Pharma in?
La Revue Pharma's product category is Professional Publishing / Pharmaceutical Trade Media. Its primary akta.pro industry code is MPAJAEAD, Health, Fitness & Wellness Magazines. Its NAICS code is 513120 and its SIC code is 2721.